A rapid, sovereign, and traceable intelligence layer for the life sciences

Myelin maps companies, assets, targets, diseases, and trials into one knowledge graph. It lets teams across the life sciences deploy agents that automate manual or repetitive workflows, with a source for every claim.

Our pilot starts soon.

Catalyst Calendar
WORKFLOWS
Catalyst Calendar
Competitor Watch
Deal Comps
Pipeline Landscape
Illustrative digest · Monday 8:00am
New retatrutide data is out.
Petosemtamab Phase 3 readout expected this quarter.
Lilly reports TRIUMPH-2: 12 mg retatrutide, 20.8% average weight loss over 80 weeks in obesity with type 2 diabetes. ↳ Lilly press release, Sept. 29, 2026
Phase 3 readout expected for petosemtamab in first-line head and neck cancer in Q4 2026. ↳ Genmab Q2 2026 results presentation, Aug. 6, 2026
Lilly plans to submit a BLA for retatrutide to the FDA in Q1 2027. ↳ Lilly Q2 2026 results, Aug. 5, 2026

Principles

Rapid

Deploy an agent in one click. It runs on a schedule and flags what changed since its last run.

Sovereign

Your files, questions, and outputs live in your organization’s private workspace. We don’t share them with other customers.

Traceable

Every claim and number cites the file or source it came from, so you can check it yourself.

Complete

Ask for every asset in an indication. You get every match we find, a count, and a reason for any candidate we left out. Counts are calculated from the underlying records.

How it works

  1. 01

    Sources

    Public trial registries such as ClinicalTrials.gov and EU CTIS, FDA and EMA documents, SEC filings, company press releases, conference abstracts and publications, plus the files your team adds.

  2. 02

    One graph

    We link them into one record per company, asset, target, disease and trial, so a readout, a deal and a trial update land in the same place.

  3. 03

    Agents

    Each agent runs on a schedule, compares against its last run, and delivers a cited digest, table or one-pager.

  4. 04

    Your team reviews

    Every line links to its source. Your team checks it and decides what to use.

One graph behind every agent

Sample view of petosemtamab with its combination partners, head-to-head comparators and same-indication competitors. Examples on this page are for illustration only and are not medical or investment advice.

Combination partner Head-to-head Same indication Drag to rotate · hover a drug to isolate its links · Ctrl/Cmd + scroll to zoom

Agents for the work your team rebuilds every week

Deploy a ready-made agent in one click.
Each runs on a schedule and delivers a cited draft for your team to check.

Every agent works from the same knowledge graph. If you run your own agents, they can query Myelin through our API and MCP server.

Competitive & commercial intelligence

Competitor Watch

A Monday digest of what changed for your competitors: trials, data, filings and deals, each cited.
Also: Access Decision Tracker · Trial Change Log
Investors & equity research

Catalyst Calendar

Readouts, filings and PDUFA dates for your watchlist, each with its source and a log of when it moved.
Also: Deck Screen · Filing Changes
Business development & M&A

Deal Comps

Licensing and M&A comps by modality and stage, each disclosed term linked to its source.
Also: Asset Scouting · Partner Mapping
Strategy & consulting

Pipeline Landscape

Every program we find in an indication, by mechanism and stage, with reasons for any left out.
Also: Indication Screen · Client Briefing
Clinical & regulatory

Competing Trials Tracker

Trials recruiting a similar patient population, by country and listed site, with changes flagged weekly.
Also: Protocol Benchmark · Regulatory Precedents
Medical affairs & research

Congress Coverage

Before each congress, the abstracts on your drugs and competitors. After it, a cited recap.
Also: Literature Watch · Target Landscape
Any team

Build your own

Coming soon: describe the task, choose the sources and set the schedule.
Also coming: Custom Tracker

Join the waitlist

Our pilot starts soon, and we’ll invite teams from the waitlist.

Questions first? Read the FAQ.

All fields are required unless marked optional.

For example, a weekly tracker of competitor readouts in NSCLC. Please leave out anything confidential.

By clicking “Join the waitlist,” you agree to our Terms of Use. We’ll use your details to run the waitlist and email you about Myelin, as our Privacy Policy explains. You can opt out anytime.

Built by a team with expertise in agentic solutions and extensive experience across the life sciences

Life-science data sits in disparate, siloed sources: registries, regulators, company filings and your own files. Pulling an analysis together by hand is slow, and the result is often incomplete. Myelin links them in one graph, with a source for every claim.

Akash Jain

Built competitive landscapes and disease assessments for biopharma clients at ClearView Healthcare Partners and Headland Strategy Group

Penn M&T, Master’s in Biotechnology

akash@usemyelin.com

Arik Li

Evaluated life sciences and healthtech companies at H.I.G. Capital and BofA Securities

Wharton

arik@usemyelin.com